Textbook of Assisted Reproductive Techniques
Two Volume Set
Herausgeber: Weissman, Ariel; Shoham, Zeev; Gardner, David K.; Howles, Colin M.
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Textbook of Assisted Reproductive Techniques
Two Volume Set
Herausgeber: Weissman, Ariel; Shoham, Zeev; Gardner, David K.; Howles, Colin M.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Established as a definitive reference for the IVF laboratory and clinic, the sixth edition has been extensively revised, with the addition of several important new contributions on clinical topics, including Artificial Intelligence, gene editing, disaster management, freeze-all cycles, immunology, and transgender considerations. As previously, methods, protocols, and techniques of choice are presented by IVF pioneers and eminent international experts. *Gives both laboratory staff and clinicians a comprehensive resource for problems arising in Reproductive Medicine *Draws on international…mehr
Established as a definitive reference for the IVF laboratory and clinic, the sixth edition has been extensively revised, with the addition of several important new contributions on clinical topics, including Artificial Intelligence, gene editing, disaster management, freeze-all cycles, immunology, and transgender considerations. As previously, methods, protocols, and techniques of choice are presented by IVF pioneers and eminent international experts. *Gives both laboratory staff and clinicians a comprehensive resource for problems arising in Reproductive Medicine *Draws on international expertise for practice and guidelines *Presents a new edition of the pre-eminent reference text in laboratory and clinical aspects of Reproductive Medicine
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd
- 6. Auflage
- Seitenzahl: 886
- Erscheinungstermin: 28. November 2023
- Englisch
- Abmessung: 228mm x 339mm x 60mm
- Gewicht: 2858g
- ISBN-13: 9781032245348
- ISBN-10: 1032245344
- Artikelnr.: 69114150
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Taylor & Francis Ltd
- 6. Auflage
- Seitenzahl: 886
- Erscheinungstermin: 28. November 2023
- Englisch
- Abmessung: 228mm x 339mm x 60mm
- Gewicht: 2858g
- ISBN-13: 9781032245348
- ISBN-10: 1032245344
- Artikelnr.: 69114150
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
David K. Gardner AM, FAA, DPhil is the Scientific Director of Melbourne IVF, and a Distinguished Professor in the School of BioSciences at the University of Melbourne, Australia. Ariel Weissman MD is a Senior Physician at the IVF Unit, Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, and a full Professor of Obstetrics and Gynecology at the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Colin M. Howles PhD, FRSM is based at Aries Consulting SARL, Geneva, Switzerland, and is an Honorary Fellow, University of Edinburgh, UK. Zeev Shoham MD is a Professor at the Hebrew University, Jerusalem, Israel, a consultant in IVF, and co-founder of IVF-Worldwide.
Volume 1: Laboratory perspectives
Preface
1. Updated guidelines for setting up an assisted reproduction technology
laboratory. 2. Quality control maintaining stability in the laboratory. 3.
KPIs for the IVF laboratory. 4. QC in the Clouds-Digitizing quality
control. 5. The assisted reproduction technology laboratory: Current
standards. 6. Evaluation of sperm. 7. Sperm preparation techniques and
advanced sperm selection for intracytoplasmic sperm injection. 8. Sperm
chromatin assessment. 9. Oocyte retrieval and selection. 10. Preparation
and evaluation of oocytes for intracytoplasmic sperm injection. 11. Use of
IVM in a clinical setting: What is its role in ART?. 12. Intracytoplasmic
sperm injection: Technical aspects. 13. Human embryo biopsy procedures. 14.
Analysis of fertilization. 15. Culture Systems for the Human Embryo. 16.
Embryo selection through the analysis of morphology and physiology. 17.
Evaluation of embryo quality: Time-lapse imaging to assess embryo
morphokinesis. 18. Artificial Intelligence (AI). 19. AI in Gamete and
Embryo Selection. 20. Demystifying vitrification. 21. Vitrification of the
Human Oocyte. 22. The human embryo: vitrification. 23. Managing an oocyte
bank. 24. Severe male factor infertility: Genetic consequences and
recommendations for genetic testing. 25. Preimplantation genetic testing
for aneuploidy to improve clinical outcomes. 26. Diagnosis of endometrial
receptivity, embryo-endometrial dialog, and endometrial microbiome. 27.
Artificial Gametes: Oocytes. 28. How microfluidics and microfabrication
will improve diagnosis and treatment in Human ART. 29. Genome Editing in
Human Reproduction. 30. Designing Disaster Plans for IVF Laboratories. 31.
Early human embryo development revealed by static imaging.
Index
Volume 2: Clinical perspectives
Preface
32. Quality management in reproductive medicine. 33. The use of
digitalisation and precision medicine in the IVF clinic. 34. Lifestyle,
periconception, and fertility. 35. Human Reproduction across the Life
Course and the Total Environment. 36. Indications for in vitro
fertilization treatment. 37. Initial investigation of the infertile couple.
38. Prognostic testing for ovarian reserve. 39. Drugs used for ovarian
stimulation: Clomiphene citrate, aromatase inhibitors, metformin,
gonadotropins, gonadotropin releasing hormone analogs, and gonadotropins.
40. The role of follicle-stimulating hormone and luteinizing hormone in
ovarian stimulation: Current concepts. 41. Endocrine characteristics of
assisted reproductive technology cycles. 42. The use of
gonadotropin-releasing hormone agonists and the efficiency of in vitro
fertilization. 43. Gonadotropin-releasing hormone antagonists in ovarian
stimulation for in vitro fertilization. 44. GnRH Agonist Triggering. 45.
Segmentation of in vitro fertilization cycles. 46. Controlled ovarian
stimulation for freeze-all cycles. 47. Immunology in ART. 48. Monitoring of
stimulated cycles in assisted reproduction. 49. Home monitoring of ART
cycles. 50. Oocyte collection. 51. Luteal phase support in assisted
reproduction techniques. 52. Treatment strategies in assisted reproduction
for the poor-responder patient. 53. The Poseidon stratification of 'Low
Prognosis Patients in ART': Management strategies and outcomes. 54.
Controlled ovarian stimulation for low responder patients. 55. Adjuvants
for poor responders. 56. Innovative therapies in Diminished Ovarian Reserve
(DOR) and Primary Ovarian Insuffiency (POI) patients. 57. Repeated
Implantation Failure. 58. Ultrasonography in Assisted Reproduction. 59.
Sperm recovery techniques: Clinical aspects and laboratory processing. 60.
Embryo Transfer Technique. 61. Cycle regimes for frozen-thawed embryo
transfer. 62. The role of the anesthesiologist in In Vitro Fertilization.
63. Endometriosis and ART. 64. Polycystic ovary syndrome and assisted
reproduction. 65. Fertility preservation strategies. 66. Uterus
transplantation - in transition from experimental to clinical procedure.
67. Viral disease and ART. 68. Fertility options for transgender and
nonbinary individuals. 69. Ovarian Hyperstimulation Syndrome. 70. Bleeding,
severe pelvic infection, and ectopic pregnancy. 71. Egg and embryo
donation. 72. Gestational surrogacy. 73. Patient support in the assisted
reproduction technology program. 74. The relationship between stress and In
Vitro Fertilization Outcome. 75. Risk and safety management in assisted
reproduction technology.
Index
Preface
1. Updated guidelines for setting up an assisted reproduction technology
laboratory. 2. Quality control maintaining stability in the laboratory. 3.
KPIs for the IVF laboratory. 4. QC in the Clouds-Digitizing quality
control. 5. The assisted reproduction technology laboratory: Current
standards. 6. Evaluation of sperm. 7. Sperm preparation techniques and
advanced sperm selection for intracytoplasmic sperm injection. 8. Sperm
chromatin assessment. 9. Oocyte retrieval and selection. 10. Preparation
and evaluation of oocytes for intracytoplasmic sperm injection. 11. Use of
IVM in a clinical setting: What is its role in ART?. 12. Intracytoplasmic
sperm injection: Technical aspects. 13. Human embryo biopsy procedures. 14.
Analysis of fertilization. 15. Culture Systems for the Human Embryo. 16.
Embryo selection through the analysis of morphology and physiology. 17.
Evaluation of embryo quality: Time-lapse imaging to assess embryo
morphokinesis. 18. Artificial Intelligence (AI). 19. AI in Gamete and
Embryo Selection. 20. Demystifying vitrification. 21. Vitrification of the
Human Oocyte. 22. The human embryo: vitrification. 23. Managing an oocyte
bank. 24. Severe male factor infertility: Genetic consequences and
recommendations for genetic testing. 25. Preimplantation genetic testing
for aneuploidy to improve clinical outcomes. 26. Diagnosis of endometrial
receptivity, embryo-endometrial dialog, and endometrial microbiome. 27.
Artificial Gametes: Oocytes. 28. How microfluidics and microfabrication
will improve diagnosis and treatment in Human ART. 29. Genome Editing in
Human Reproduction. 30. Designing Disaster Plans for IVF Laboratories. 31.
Early human embryo development revealed by static imaging.
Index
Volume 2: Clinical perspectives
Preface
32. Quality management in reproductive medicine. 33. The use of
digitalisation and precision medicine in the IVF clinic. 34. Lifestyle,
periconception, and fertility. 35. Human Reproduction across the Life
Course and the Total Environment. 36. Indications for in vitro
fertilization treatment. 37. Initial investigation of the infertile couple.
38. Prognostic testing for ovarian reserve. 39. Drugs used for ovarian
stimulation: Clomiphene citrate, aromatase inhibitors, metformin,
gonadotropins, gonadotropin releasing hormone analogs, and gonadotropins.
40. The role of follicle-stimulating hormone and luteinizing hormone in
ovarian stimulation: Current concepts. 41. Endocrine characteristics of
assisted reproductive technology cycles. 42. The use of
gonadotropin-releasing hormone agonists and the efficiency of in vitro
fertilization. 43. Gonadotropin-releasing hormone antagonists in ovarian
stimulation for in vitro fertilization. 44. GnRH Agonist Triggering. 45.
Segmentation of in vitro fertilization cycles. 46. Controlled ovarian
stimulation for freeze-all cycles. 47. Immunology in ART. 48. Monitoring of
stimulated cycles in assisted reproduction. 49. Home monitoring of ART
cycles. 50. Oocyte collection. 51. Luteal phase support in assisted
reproduction techniques. 52. Treatment strategies in assisted reproduction
for the poor-responder patient. 53. The Poseidon stratification of 'Low
Prognosis Patients in ART': Management strategies and outcomes. 54.
Controlled ovarian stimulation for low responder patients. 55. Adjuvants
for poor responders. 56. Innovative therapies in Diminished Ovarian Reserve
(DOR) and Primary Ovarian Insuffiency (POI) patients. 57. Repeated
Implantation Failure. 58. Ultrasonography in Assisted Reproduction. 59.
Sperm recovery techniques: Clinical aspects and laboratory processing. 60.
Embryo Transfer Technique. 61. Cycle regimes for frozen-thawed embryo
transfer. 62. The role of the anesthesiologist in In Vitro Fertilization.
63. Endometriosis and ART. 64. Polycystic ovary syndrome and assisted
reproduction. 65. Fertility preservation strategies. 66. Uterus
transplantation - in transition from experimental to clinical procedure.
67. Viral disease and ART. 68. Fertility options for transgender and
nonbinary individuals. 69. Ovarian Hyperstimulation Syndrome. 70. Bleeding,
severe pelvic infection, and ectopic pregnancy. 71. Egg and embryo
donation. 72. Gestational surrogacy. 73. Patient support in the assisted
reproduction technology program. 74. The relationship between stress and In
Vitro Fertilization Outcome. 75. Risk and safety management in assisted
reproduction technology.
Index
Volume 1: Laboratory perspectives
Preface
1. Updated guidelines for setting up an assisted reproduction technology
laboratory. 2. Quality control maintaining stability in the laboratory. 3.
KPIs for the IVF laboratory. 4. QC in the Clouds-Digitizing quality
control. 5. The assisted reproduction technology laboratory: Current
standards. 6. Evaluation of sperm. 7. Sperm preparation techniques and
advanced sperm selection for intracytoplasmic sperm injection. 8. Sperm
chromatin assessment. 9. Oocyte retrieval and selection. 10. Preparation
and evaluation of oocytes for intracytoplasmic sperm injection. 11. Use of
IVM in a clinical setting: What is its role in ART?. 12. Intracytoplasmic
sperm injection: Technical aspects. 13. Human embryo biopsy procedures. 14.
Analysis of fertilization. 15. Culture Systems for the Human Embryo. 16.
Embryo selection through the analysis of morphology and physiology. 17.
Evaluation of embryo quality: Time-lapse imaging to assess embryo
morphokinesis. 18. Artificial Intelligence (AI). 19. AI in Gamete and
Embryo Selection. 20. Demystifying vitrification. 21. Vitrification of the
Human Oocyte. 22. The human embryo: vitrification. 23. Managing an oocyte
bank. 24. Severe male factor infertility: Genetic consequences and
recommendations for genetic testing. 25. Preimplantation genetic testing
for aneuploidy to improve clinical outcomes. 26. Diagnosis of endometrial
receptivity, embryo-endometrial dialog, and endometrial microbiome. 27.
Artificial Gametes: Oocytes. 28. How microfluidics and microfabrication
will improve diagnosis and treatment in Human ART. 29. Genome Editing in
Human Reproduction. 30. Designing Disaster Plans for IVF Laboratories. 31.
Early human embryo development revealed by static imaging.
Index
Volume 2: Clinical perspectives
Preface
32. Quality management in reproductive medicine. 33. The use of
digitalisation and precision medicine in the IVF clinic. 34. Lifestyle,
periconception, and fertility. 35. Human Reproduction across the Life
Course and the Total Environment. 36. Indications for in vitro
fertilization treatment. 37. Initial investigation of the infertile couple.
38. Prognostic testing for ovarian reserve. 39. Drugs used for ovarian
stimulation: Clomiphene citrate, aromatase inhibitors, metformin,
gonadotropins, gonadotropin releasing hormone analogs, and gonadotropins.
40. The role of follicle-stimulating hormone and luteinizing hormone in
ovarian stimulation: Current concepts. 41. Endocrine characteristics of
assisted reproductive technology cycles. 42. The use of
gonadotropin-releasing hormone agonists and the efficiency of in vitro
fertilization. 43. Gonadotropin-releasing hormone antagonists in ovarian
stimulation for in vitro fertilization. 44. GnRH Agonist Triggering. 45.
Segmentation of in vitro fertilization cycles. 46. Controlled ovarian
stimulation for freeze-all cycles. 47. Immunology in ART. 48. Monitoring of
stimulated cycles in assisted reproduction. 49. Home monitoring of ART
cycles. 50. Oocyte collection. 51. Luteal phase support in assisted
reproduction techniques. 52. Treatment strategies in assisted reproduction
for the poor-responder patient. 53. The Poseidon stratification of 'Low
Prognosis Patients in ART': Management strategies and outcomes. 54.
Controlled ovarian stimulation for low responder patients. 55. Adjuvants
for poor responders. 56. Innovative therapies in Diminished Ovarian Reserve
(DOR) and Primary Ovarian Insuffiency (POI) patients. 57. Repeated
Implantation Failure. 58. Ultrasonography in Assisted Reproduction. 59.
Sperm recovery techniques: Clinical aspects and laboratory processing. 60.
Embryo Transfer Technique. 61. Cycle regimes for frozen-thawed embryo
transfer. 62. The role of the anesthesiologist in In Vitro Fertilization.
63. Endometriosis and ART. 64. Polycystic ovary syndrome and assisted
reproduction. 65. Fertility preservation strategies. 66. Uterus
transplantation - in transition from experimental to clinical procedure.
67. Viral disease and ART. 68. Fertility options for transgender and
nonbinary individuals. 69. Ovarian Hyperstimulation Syndrome. 70. Bleeding,
severe pelvic infection, and ectopic pregnancy. 71. Egg and embryo
donation. 72. Gestational surrogacy. 73. Patient support in the assisted
reproduction technology program. 74. The relationship between stress and In
Vitro Fertilization Outcome. 75. Risk and safety management in assisted
reproduction technology.
Index
Preface
1. Updated guidelines for setting up an assisted reproduction technology
laboratory. 2. Quality control maintaining stability in the laboratory. 3.
KPIs for the IVF laboratory. 4. QC in the Clouds-Digitizing quality
control. 5. The assisted reproduction technology laboratory: Current
standards. 6. Evaluation of sperm. 7. Sperm preparation techniques and
advanced sperm selection for intracytoplasmic sperm injection. 8. Sperm
chromatin assessment. 9. Oocyte retrieval and selection. 10. Preparation
and evaluation of oocytes for intracytoplasmic sperm injection. 11. Use of
IVM in a clinical setting: What is its role in ART?. 12. Intracytoplasmic
sperm injection: Technical aspects. 13. Human embryo biopsy procedures. 14.
Analysis of fertilization. 15. Culture Systems for the Human Embryo. 16.
Embryo selection through the analysis of morphology and physiology. 17.
Evaluation of embryo quality: Time-lapse imaging to assess embryo
morphokinesis. 18. Artificial Intelligence (AI). 19. AI in Gamete and
Embryo Selection. 20. Demystifying vitrification. 21. Vitrification of the
Human Oocyte. 22. The human embryo: vitrification. 23. Managing an oocyte
bank. 24. Severe male factor infertility: Genetic consequences and
recommendations for genetic testing. 25. Preimplantation genetic testing
for aneuploidy to improve clinical outcomes. 26. Diagnosis of endometrial
receptivity, embryo-endometrial dialog, and endometrial microbiome. 27.
Artificial Gametes: Oocytes. 28. How microfluidics and microfabrication
will improve diagnosis and treatment in Human ART. 29. Genome Editing in
Human Reproduction. 30. Designing Disaster Plans for IVF Laboratories. 31.
Early human embryo development revealed by static imaging.
Index
Volume 2: Clinical perspectives
Preface
32. Quality management in reproductive medicine. 33. The use of
digitalisation and precision medicine in the IVF clinic. 34. Lifestyle,
periconception, and fertility. 35. Human Reproduction across the Life
Course and the Total Environment. 36. Indications for in vitro
fertilization treatment. 37. Initial investigation of the infertile couple.
38. Prognostic testing for ovarian reserve. 39. Drugs used for ovarian
stimulation: Clomiphene citrate, aromatase inhibitors, metformin,
gonadotropins, gonadotropin releasing hormone analogs, and gonadotropins.
40. The role of follicle-stimulating hormone and luteinizing hormone in
ovarian stimulation: Current concepts. 41. Endocrine characteristics of
assisted reproductive technology cycles. 42. The use of
gonadotropin-releasing hormone agonists and the efficiency of in vitro
fertilization. 43. Gonadotropin-releasing hormone antagonists in ovarian
stimulation for in vitro fertilization. 44. GnRH Agonist Triggering. 45.
Segmentation of in vitro fertilization cycles. 46. Controlled ovarian
stimulation for freeze-all cycles. 47. Immunology in ART. 48. Monitoring of
stimulated cycles in assisted reproduction. 49. Home monitoring of ART
cycles. 50. Oocyte collection. 51. Luteal phase support in assisted
reproduction techniques. 52. Treatment strategies in assisted reproduction
for the poor-responder patient. 53. The Poseidon stratification of 'Low
Prognosis Patients in ART': Management strategies and outcomes. 54.
Controlled ovarian stimulation for low responder patients. 55. Adjuvants
for poor responders. 56. Innovative therapies in Diminished Ovarian Reserve
(DOR) and Primary Ovarian Insuffiency (POI) patients. 57. Repeated
Implantation Failure. 58. Ultrasonography in Assisted Reproduction. 59.
Sperm recovery techniques: Clinical aspects and laboratory processing. 60.
Embryo Transfer Technique. 61. Cycle regimes for frozen-thawed embryo
transfer. 62. The role of the anesthesiologist in In Vitro Fertilization.
63. Endometriosis and ART. 64. Polycystic ovary syndrome and assisted
reproduction. 65. Fertility preservation strategies. 66. Uterus
transplantation - in transition from experimental to clinical procedure.
67. Viral disease and ART. 68. Fertility options for transgender and
nonbinary individuals. 69. Ovarian Hyperstimulation Syndrome. 70. Bleeding,
severe pelvic infection, and ectopic pregnancy. 71. Egg and embryo
donation. 72. Gestational surrogacy. 73. Patient support in the assisted
reproduction technology program. 74. The relationship between stress and In
Vitro Fertilization Outcome. 75. Risk and safety management in assisted
reproduction technology.
Index